Emily M. Leproust - Dec 27, 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
President & CEO, Director
Signature
/s/ William Solis, as Attorney-in-Fact for Emily M. Leproust
Stock symbol
TWST
Transactions as of
Dec 27, 2021
Transactions value $
-$428,780
Form type
4
Date filed
12/29/2021, 03:35 PM
Previous filing
Dec 10, 2021
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Gift $0 -1.15K -0.69% $0.00 165K Dec 22, 2021 Direct
transaction TWST Common Stock Sale -$157K -1.96K -1.19% $80.12 163K Dec 27, 2021 Direct F1, F2
transaction TWST Common Stock Sale -$157K -1.94K -1.19% $80.86 161K Dec 27, 2021 Direct F1, F3
transaction TWST Common Stock Sale -$90K -1.1K -0.68% $81.83 160K Dec 27, 2021 Direct F1, F4
transaction TWST Common Stock Sale -$16.5K -200 -0.13% $82.43 160K Dec 27, 2021 Direct F1, F5
transaction TWST Common Stock Sale -$8.38K -100 -0.06% $83.80 160K Dec 27, 2021 Direct F1
transaction TWST Common Stock Award $0 +16.8K +10.56% $0.00 176K Dec 27, 2021 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TWST Employee Stock Option (right to buy) 267K Dec 27, 2021 Common Stock 0 $26.66 Direct F7
holding TWST Employee Stock Option (right to buy) 131K Dec 27, 2021 Common Stock 0 $23.33 Direct F8
holding TWST Employee Stock Option (right to buy) 163K Dec 27, 2021 Common Stock 0 $8.82 Direct F9
holding TWST Employee Stock Option (right to buy) 35.9K Dec 27, 2021 Common Stock 0 $5.95 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 28, 2021.
F2 Represents the weighted average sales price per share. The shares sold at prices ranging from $79.35 to $80.34 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F3 Represents the weighted average sales price per share. The shares sold at prices ranging from $80.395 to $81.34 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F4 Represents the weighted average sales price per share. The shares sold at prices ranging from $81.40 to $82.12 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F5 Represents the weighted average sales price per share. The shares sold at prices ranging from $82.40 to $82.46 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F6 Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of October 1, 2021, for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.
F7 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F8 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F9 The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F10 The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.